Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results82% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (5)

Trial Status

Completed9
Terminated2
Unknown2

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (13)

Research Network

Activity Timeline